Home/Filings/4/0001209191-12-024601
4//SEC Filing

DERBYSHIRE ADAM C 4

Accession 0001209191-12-024601

CIK 0001009356other

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 3:54 PM ET

Size

8.5 KB

Accession

0001209191-12-024601

Insider Transaction Report

Form 4
Period: 2012-04-25
DERBYSHIRE ADAM C
EVP Finance/CFO
Transactions
  • Award

    Common Stock

    2012-04-25+21,711152,849 total
Holdings
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (20,000 underlying)
    20,000
  • Option to Buy Common Stock

    Exercise: $8.00Exp: 2013-05-30Common Stock (90,000 underlying)
    90,000
  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17Common Stock (30,000 underlying)
    30,000
Footnotes (2)
  • [F1]Represents a restricted stock award which vests annually in four equal installments beginning January 1, 2013, subject to continued employment.
  • [F2]Options are 100% vested.

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeother

Related Parties

1
  • filerCIK 0001212669

Filing Metadata

Form type
4
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 3:54 PM ET
Size
8.5 KB